BOD Science Ltd Cash Flow Conversion Efficiency
BOD Science Ltd cash flow conversion efficiency. Based on the latest financial reports, BOD Science Ltd (BOD) has a cash flow conversion efficiency ratio of -0.175x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$900.22K ≈ $636.96K USD) by net assets (AU$-5.15 Million ≈ $-3.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BOD Science Ltd (2016–2025)
Cash flow conversion efficiency of BOD Science Ltd from 2016 to 2025. This chart illustrates how BOD Science Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for BOD Science Ltd for real-time trading data and today's change.
BOD Science Ltd Cash Flow Conversion Ratio Explained
BOD Science Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BOD Science Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BOD Science Ltd ranked by their cash flow conversion efficiency. Also see BOD Science Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Secure Trust Bank PLC
LSE:STB
|
0.093x |
|
Tarrina Resources Limited
AU:TR8
|
-0.020x |
|
WOODPECKER.CO ZY -10
F:8FG
|
0.066x |
|
Real Estate Credit Investments Limited
LSE:RECI
|
-0.049x |
|
Ridgetech, Inc.
NASDAQ:RDGT
|
-0.165x |
|
FIRST CLASS MET. LS-001
F:WN9
|
N/A |
|
Ankit Metal & Power Limited
NSE:ANKITMETAL
|
-0.018x |
|
Telemasters Holdings Ltd
JSE:TLM
|
0.033x |
Annual Cash Flow Conversion Efficiency for BOD Science Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of BOD Science Ltd from 2016 to 2025. Review BOD cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-5.15 Million ≈ $-3.65 Million |
AU$937.08K ≈ $663.04K |
-0.182x | -205.79% |
| 2024-06-30 | AU$-5.32 Million ≈ $-3.76 Million |
AU$-913.98K ≈ $-646.70K |
0.172x | -97.87% |
| 2023-06-30 | AU$-703.36K ≈ $-497.67K |
AU$-5.68 Million ≈ $-4.02 Million |
8.072x | +770.07% |
| 2022-06-30 | AU$3.47 Million ≈ $2.45 Million |
AU$-4.18 Million ≈ $-2.96 Million |
-1.205x | -78.87% |
| 2021-06-30 | AU$8.66 Million ≈ $6.13 Million |
AU$-5.83 Million ≈ $-4.13 Million |
-0.674x | -0.44% |
| 2020-06-30 | AU$4.81 Million ≈ $3.40 Million |
AU$-3.22 Million ≈ $-2.28 Million |
-0.671x | +78.63% |
| 2019-06-30 | AU$2.07 Million ≈ $1.46 Million |
AU$-6.48 Million ≈ $-4.59 Million |
-3.137x | -177.39% |
| 2018-06-30 | AU$2.62 Million ≈ $1.85 Million |
AU$-2.96 Million ≈ $-2.10 Million |
-1.131x | -43.54% |
| 2017-06-30 | AU$3.00 Million ≈ $2.12 Million |
AU$-2.36 Million ≈ $-1.67 Million |
-0.788x | -1925.02% |
| 2016-06-30 | AU$5.52 Million ≈ $3.91 Million |
AU$-214.91K ≈ $-152.07K |
-0.039x | -- |
About BOD Science Ltd
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and dis… Read more